Amylin's $1 billion heavyweight deal.
Hayley
H
Birch
D000682:Amyloid / Q000191:economics* / Q000627:therapeutic use*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007373:Interinstitutional Relations; D058228:Islet Amyloid Polypeptide; D007564:Japan; D020738:Leptin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy* / Q000191:economics*; D014481:United States
D000682:Amyloid; D058228:Islet Amyloid Polypeptide; D020738:Leptin; C105254:pramlintide; C415771:metreleptin